- Report
- October 2024
- 183 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Etofibrate is a class of cardiovascular drugs used to treat high cholesterol and triglyceride levels. It works by increasing the activity of lipoprotein lipase, an enzyme that helps break down fats in the blood. It also helps reduce the production of very low-density lipoprotein (VLDL) cholesterol, which is a major risk factor for heart disease. Etofibrate is usually prescribed in combination with a low-fat diet and exercise.
Etofibrate is available in both generic and brand-name formulations. Common brand names include Tricor, Lofibra, and Triglide. It is available in tablet, capsule, and liquid forms.
Etofibrate is generally well-tolerated, but side effects can include nausea, abdominal pain, and muscle pain. It is important to discuss any potential risks with a doctor before taking this medication.
Some companies in the Etofibrate market include AbbVie, Merck, and Pfizer. Show Less Read more